APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

1,3-Thiazolidine-2,4-Dione

1,3-Thiazolidine-2,4-Dione is a heterocyclic chemical substance identified by its named ring and substituent structure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which supplied interfaces and acceptance criteria define 1,3-Thiazolidine-2,4-Dione?

The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.

Selected research

Market Outlook & Growth Opportunities

Global 1,3-Thiazolidine-2,4-Dione Market Outlook and Growth Opportunities 2026

Report ID 17427728054 July 2026192 pages

Choose your research edition.

Industry Research1,3-Thiazolidine-2,4-Dione Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal 1,3-Thiazolidine-2,4-Dione Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal 1,3-Thiazolidine-2,4-Dione Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 1,3-Thiazolidine-2,4-Dione Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal 1,3-Thiazolidine-2,4-Dione Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global 1,3-Thiazolidine-2,4-Dione market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 1,3-Thiazolidine-2,4-Dione is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 1,3-Thiazolidine-2,4-Dione market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 1,3-Thiazolidine-2,4-Dione market include ShanDong Believe Chemical, Jinan Shengqi Pharmaceutical, Hangzhou Ribo Pharmaceutical, Dezhou Haizhi Pharma, Siwei Development Group, Sarex and Robinson Brothers, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 1,3-Thiazolidine-2,4-Dione market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 1,3-Thiazolidine-2,4-Dione and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 1,3-Thiazolidine-2,4-Dione sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 1,3-Thiazolidine-2,4-Dione market size, projected growth trends, production technologies, key applications, and end-use industries.

1,3-Thiazolidine-2,4-Dione Segment by Company

ShanDong Believe Chemical

Jinan Shengqi Pharmaceutical

Hangzhou Ribo Pharmaceutical

Dezhou Haizhi Pharma

Siwei Development Group

Sarex

Robinson Brothers

1,3-Thiazolidine-2,4-Dione Segment by Type

Purity ≥98%

Purity ≥99%

Others

1,3-Thiazolidine-2,4-Dione Segment by Application

Pioglitazone Intermediate

Rosiglitazone Intermediate

Others

1,3-Thiazolidine-2,4-Dione Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 1,3-Thiazolidine-2,4-Dione status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 1,3-Thiazolidine-2,4-Dione market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 1,3-Thiazolidine-2,4-Dione significant trends, drivers, influence factors in global and regions.

6. To analyze 1,3-Thiazolidine-2,4-Dione competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1,3-Thiazolidine-2,4-Dione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 1,3-Thiazolidine-2,4-Dione and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1,3-Thiazolidine-2,4-Dione.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 1,3-Thiazolidine-2,4-Dione market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 1,3-Thiazolidine-2,4-Dione industry.

Chapter 3: Detailed analysis of 1,3-Thiazolidine-2,4-Dione manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 1,3-Thiazolidine-2,4-Dione in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 1,3-Thiazolidine-2,4-Dione in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 1,3-Thiazolidine-2,4-Dione Industry Trends Table 2. 1,3-Thiazolidine-2,4-Dione Industry Drivers Table 3. 1,3-Thiazolidine-2,4-Dione Industry Opportunities and Challenges Table 4. 1,3-Thiazolidine-2,4-Dione Industry Restraints Table 5. Global 1,3-Thiazolidine-2,4-Dione Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 1,3-Thiazolidine-2,4-Dione Revenue Share by Company (2021-2026) Table 7. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Company (t) & (2021-2026) Table 8. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Company (2021-2026) Table 9. Global 1,3-Thiazolidine-2,4-Dione Average Price (USD/t) of Company (2021-2026) Table 10. Global 1,3-Thiazolidine-2,4-Dione Company Ranking, (2024-2026) & (USD Million) Table 11. Global 1,3-Thiazolidine-2,4-Dione Key Company Manufacturing Base & Headquarters Table 12. Global 1,3-Thiazolidine-2,4-Dione Company, Product Type & Application Table 13. Global 1,3-Thiazolidine-2,4-Dione Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 1,3-Thiazolidine-2,4-Dione by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥98% Table 18. Significant Companies of Purity ≥99% Table 19. Significant Companies of Others Table 20. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type (2021-2026) & (t) Table 22. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type (2027-2032) & (t) Table 23. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Type (2021-2026) Table 24. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Type (2027-2032) Table 25. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type (2021-2026) Table 29. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pioglitazone Intermediate Table 31. Significant Companies of Rosiglitazone Intermediate Table 32. Significant Companies of Others Table 33. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application (2021-2026) & (t) Table 35. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application (2027-2032) & (t) Table 36. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Application (2021-2026) Table 37. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Application (2027-2032) Table 38. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application (2021-2026) Table 42. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application (2027-2032) Table 43. Global 1,3-Thiazolidine-2,4-Dione Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global 1,3-Thiazolidine-2,4-Dione Sales by Region (2021-2026) & (t) Table 45. Global 1,3-Thiazolidine-2,4-Dione Sales Market Share by Region (2021-2026) Table 46. Global 1,3-Thiazolidine-2,4-Dione Sales by Region (2027-2032) & (t) Table 47. Global 1,3-Thiazolidine-2,4-Dione Sales Market Share by Region (2027-2032) Table 48. Global 1,3-Thiazolidine-2,4-Dione Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Region (2021-2026) Table 51. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Region (2027-2032) Table 53. Global 1,3-Thiazolidine-2,4-Dione Market Average Price (USD/t) by Region (2021-2026) Table 54. Global 1,3-Thiazolidine-2,4-Dione Market Average Price (USD/t) by Region (2027-2032) Table 55. Global 1,3-Thiazolidine-2,4-Dione Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global 1,3-Thiazolidine-2,4-Dione Sales by Country (2021-2026) & (t) Table 58. Global 1,3-Thiazolidine-2,4-Dione Sales Market Share by Country (2021-2026) Table 59. Global 1,3-Thiazolidine-2,4-Dione Sales by Country (2027-2032) & (t) Table 60. Global 1,3-Thiazolidine-2,4-Dione Sales Market Share by Country (2027-2032) Table 61. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global 1,3-Thiazolidine-2,4-Dione Sales Value Market Share by Country (2021-2026) Table 63. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global 1,3-Thiazolidine-2,4-Dione Sales Value Market Share by Country (2027-2032) Table 65. ShanDong Believe Chemical Company Information Table 66. ShanDong Believe Chemical Business Overview Table 67. ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 69. ShanDong Believe Chemical Recent Development Table 70. Jinan Shengqi Pharmaceutical Company Information Table 71. Jinan Shengqi Pharmaceutical Business Overview Table 72. Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 74. Jinan Shengqi Pharmaceutical Recent Development Table 75. Hangzhou Ribo Pharmaceutical Company Information Table 76. Hangzhou Ribo Pharmaceutical Business Overview Table 77. Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 79. Hangzhou Ribo Pharmaceutical Recent Development Table 80. Dezhou Haizhi Pharma Company Information Table 81. Dezhou Haizhi Pharma Business Overview Table 82. Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 84. Dezhou Haizhi Pharma Recent Development Table 85. Siwei Development Group Company Information Table 86. Siwei Development Group Business Overview Table 87. Siwei Development Group 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Siwei Development Group 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 89. Siwei Development Group Recent Development Table 90. Sarex Company Information Table 91. Sarex Business Overview Table 92. Sarex 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Sarex 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 94. Sarex Recent Development Table 95. Robinson Brothers Company Information Table 96. Robinson Brothers Business Overview Table 97. Robinson Brothers 1,3-Thiazolidine-2,4-Dione Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Robinson Brothers 1,3-Thiazolidine-2,4-Dione Product Portfolio Table 99. Robinson Brothers Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. 1,3-Thiazolidine-2,4-Dione Distributors List Table 103. 1,3-Thiazolidine-2,4-Dione Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. 1,3-Thiazolidine-2,4-Dione Product Image Figure 2. Global 1,3-Thiazolidine-2,4-Dione Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 4. Global 1,3-Thiazolidine-2,4-Dione Sales (2021-2032) & (t) Figure 5. Global 1,3-Thiazolidine-2,4-Dione Sales Average Price (USD/t) & (2021-2032) Figure 6. Global 1,3-Thiazolidine-2,4-Dione Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥98% Image Figure 10. Purity ≥99% Image Figure 11. Others Image Figure 12. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Type (2021-2032) Figure 15. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type (2021-2032) Figure 18. Pioglitazone Intermediate Image Figure 19. Rosiglitazone Intermediate Image Figure 20. Others Image Figure 21. Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Application (2021-2032) Figure 24. Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application (2021-2032) Figure 27. Global 1,3-Thiazolidine-2,4-Dione Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global 1,3-Thiazolidine-2,4-Dione Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global 1,3-Thiazolidine-2,4-Dione Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 32. North America 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 34. Europe 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 38. South America 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. 1,3-Thiazolidine-2,4-Dione Value Chain Figure 126. Manufacturing Cost Structure Figure 127. 1,3-Thiazolidine-2,4-Dione Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥98%
  • Purity ≥99%
  • Others
Applications
  • Pioglitazone Intermediate
  • Rosiglitazone Intermediate
  • Others
Companies covered
  • ShanDong Believe Chemical
  • Jinan Shengqi Pharmaceutical
  • Hangzhou Ribo Pharmaceutical
  • Dezhou Haizhi Pharma
  • Siwei Development Group
  • Sarex
  • Robinson Brothers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  4. 1.2.2 Global 1,3-Thiazolidine-2,4-Dione Sales Volume (2021-2032)
  5. 1.2.3 Global 1,3-Thiazolidine-2,4-Dione Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 1,3-Thiazolidine-2,4-Dione Market Dynamics
  1. 2.1 1,3-Thiazolidine-2,4-Dione Industry Trends
  2. 2.2 1,3-Thiazolidine-2,4-Dione Industry Drivers
  3. 2.3 1,3-Thiazolidine-2,4-Dione Industry Opportunities and Challenges
  4. 2.4 1,3-Thiazolidine-2,4-Dione Industry Restraints
3 1,3-Thiazolidine-2,4-Dione Market by Company
  1. 3.1 Global 1,3-Thiazolidine-2,4-Dione Company Revenue Ranking in 2025
  2. 3.2 Global 1,3-Thiazolidine-2,4-Dione Revenue by Company (2021-2026)
  3. 3.3 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Company (2021-2026)
  4. 3.4 Global 1,3-Thiazolidine-2,4-Dione Average Price by Company (2021-2026)
  5. 3.5 Global 1,3-Thiazolidine-2,4-Dione Company Ranking (2024-2026)
  6. 3.6 Global 1,3-Thiazolidine-2,4-Dione Company Manufacturing Base and Headquarters
  7. 3.7 Global 1,3-Thiazolidine-2,4-Dione Company Product Type and Application
  8. 3.8 Global 1,3-Thiazolidine-2,4-Dione Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 1,3-Thiazolidine-2,4-Dione Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 1,3-Thiazolidine-2,4-Dione Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 1,3-Thiazolidine-2,4-Dione Market by Type
  1. 4.1 1,3-Thiazolidine-2,4-Dione Type Introduction
  2. 4.1.1 Purity ≥98%
  3. 4.1.2 Purity ≥99%
  4. 4.1.3 Others
  5. 4.2 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type
  6. 4.2.1 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Type (2021-2032)
  8. 4.2.3 Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Type (2021-2032)
  9. 4.3 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type
  10. 4.3.1 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Type (2021-2032)
  12. 4.3.3 Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type (2021-2032)
5 1,3-Thiazolidine-2,4-Dione Market by Application
  1. 5.1 1,3-Thiazolidine-2,4-Dione Application Introduction
  2. 5.1.1 Pioglitazone Intermediate
  3. 5.1.2 Rosiglitazone Intermediate
  4. 5.1.3 Others
  5. 5.2 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application
  6. 5.2.1 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global 1,3-Thiazolidine-2,4-Dione Sales Volume by Application (2021-2032)
  8. 5.2.3 Global 1,3-Thiazolidine-2,4-Dione Sales Volume Share by Application (2021-2032)
  9. 5.3 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application
  10. 5.3.1 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Application (2021-2032)
  12. 5.3.3 Global 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application (2021-2032)
6 1,3-Thiazolidine-2,4-Dione Regional Sales and Value Analysis
  1. 6.1 Global 1,3-Thiazolidine-2,4-Dione Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 1,3-Thiazolidine-2,4-Dione Sales by Region (2021-2032)
  3. 6.2.1 Global 1,3-Thiazolidine-2,4-Dione Sales by Region: 2021-2026
  4. 6.2.2 Global 1,3-Thiazolidine-2,4-Dione Sales by Region (2027-2032)
  5. 6.3 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region (2021-2032)
  7. 6.4.1 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region: 2021-2026
  8. 6.4.2 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Region (2027-2032)
  9. 6.5 Global 1,3-Thiazolidine-2,4-Dione Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  12. 6.6.2 North America 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  15. 6.7.2 Europe 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  21. 6.9.2 South America 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 1,3-Thiazolidine-2,4-Dione Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 1,3-Thiazolidine-2,4-Dione Sales Value Share by Country, 2025 VS 2032
7 1,3-Thiazolidine-2,4-Dione Country-level Sales and Value Analysis
  1. 7.1 Global 1,3-Thiazolidine-2,4-Dione Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 1,3-Thiazolidine-2,4-Dione Sales by Country (2021-2032)
  4. 7.3.1 Global 1,3-Thiazolidine-2,4-Dione Sales by Country (2021-2026)
  5. 7.3.2 Global 1,3-Thiazolidine-2,4-Dione Sales by Country (2027-2032)
  6. 7.4 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country (2021-2032)
  7. 7.4.1 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country (2021-2026)
  8. 7.4.2 Global 1,3-Thiazolidine-2,4-Dione Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 1,3-Thiazolidine-2,4-Dione Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ShanDong Believe Chemical
  2. 8.1.1 ShanDong Believe Chemical Company Information
  3. 8.1.2 ShanDong Believe Chemical Business Overview
  4. 8.1.3 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Product Portfolio
  6. 8.1.5 ShanDong Believe Chemical Recent Developments
  7. 8.2 Jinan Shengqi Pharmaceutical
  8. 8.2.1 Jinan Shengqi Pharmaceutical Company Information
  9. 8.2.2 Jinan Shengqi Pharmaceutical Business Overview
  10. 8.2.3 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio
  12. 8.2.5 Jinan Shengqi Pharmaceutical Recent Developments
  13. 8.3 Hangzhou Ribo Pharmaceutical
  14. 8.3.1 Hangzhou Ribo Pharmaceutical Company Information
  15. 8.3.2 Hangzhou Ribo Pharmaceutical Business Overview
  16. 8.3.3 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Product Portfolio
  18. 8.3.5 Hangzhou Ribo Pharmaceutical Recent Developments
  19. 8.4 Dezhou Haizhi Pharma
  20. 8.4.1 Dezhou Haizhi Pharma Company Information
  21. 8.4.2 Dezhou Haizhi Pharma Business Overview
  22. 8.4.3 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Product Portfolio
  24. 8.4.5 Dezhou Haizhi Pharma Recent Developments
  25. 8.5 Siwei Development Group
  26. 8.5.1 Siwei Development Group Company Information
  27. 8.5.2 Siwei Development Group Business Overview
  28. 8.5.3 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Product Portfolio
  30. 8.5.5 Siwei Development Group Recent Developments
  31. 8.6 Sarex
  32. 8.6.1 Sarex Company Information
  33. 8.6.2 Sarex Business Overview
  34. 8.6.3 Sarex 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sarex 1,3-Thiazolidine-2,4-Dione Product Portfolio
  36. 8.6.5 Sarex Recent Developments
  37. 8.7 Robinson Brothers
  38. 8.7.1 Robinson Brothers Company Information
  39. 8.7.2 Robinson Brothers Business Overview
  40. 8.7.3 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Product Portfolio
  42. 8.7.5 Robinson Brothers Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 1,3-Thiazolidine-2,4-Dione Value Chain Analysis
  2. 9.1.1 1,3-Thiazolidine-2,4-Dione Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 1,3-Thiazolidine-2,4-Dione Sales Mode & Process
  6. 9.2 1,3-Thiazolidine-2,4-Dione Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 1,3-Thiazolidine-2,4-Dione Distributors
  9. 9.2.3 1,3-Thiazolidine-2,4-Dione Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst